The company's advanced diagnostics simplify and improve COVID-19 antibody monitoring, rapid acute lung injury testing, donor organ transplant informatics, and immunological protein and antibody testing. SQI Diagnostics provides laboratories and clinical research organizations with the ability to simultaneously analyze customized multiple biomarkers down to the isotype and subclass levels, deliver accurate and quantitative patient results in an IVD format in less time, significantly reduce labor and increase profits. Its tests run on SQI's automated systems, and the company's proprietary advanced diagnostics target organ transplant, autoimmune disease and COVID-19 testing.